Look Beyond Molecular Testing to Predict Response to Immunotherapy Agents, Study Says
For all their potential to curb or even cure some cancers, drugs known as immune checkpoint inhibitors come with a caveat: They’re effective in only a subset of patients. Predicting who those patients are, and understanding why others don’t respond as well, remains a major challenge. In a new study, researchers at Dana-Farber in collaboration … Read more